Owlet, Inc. (NYSE: OWLTW)

Owlet, Inc. is a digital parenting platform company that provides real-time data and insights to parents through connected hardware products and associated mobile applications. The company designs, develops, and sells wearable infant monitoring devices that track vital signs such as heart rate and oxygen levels, aiming to empower parents with information to feel more confident and rested. Its core mission centers on supporting infant health and parental well-being through technology-driven solutions in the consumer baby care market.

Owlet generates revenue primarily from the sale of its hardware products, including the Dream Sock and Dream Duo infant monitors, which are sold directly to consumers through online retail channels and third-party distributors. A growing portion of revenue comes from the Owlet360 subscription service, which launched in January 2025 and provides parents with enhanced app features, sleep insights, and wellness tracking through a recurring monthly fee. Revenue is recognized when control of goods or services transfers to the customer, reflecting the expected consideration in exchange for those products or services.

The company operates through the following segments:

• Product Sales: This segment includes the design, manufacturing, and sale of wearable infant monitoring devices such as the Dream Sock and Dream Duo, which track heart rate, oxygen levels, and sleep patterns for infants, along with associated hardware accessories and fulfillment services.

• Subscription Services: This segment encompasses the Owlet360 platform, a software-based service offering parents advanced analytics, sleep coaching, and wellness tracking through a mobile application, delivered on a recurring basis to enhance the core product experience and drive ongoing customer engagement.

Owlet operates in the competitive consumer baby technology market, where it faces competition from other infant monitoring brands such as Nanit, Miku, and Angelcare, as well as broader smart nursery players. Its competitive advantage lies in being one of the first to market with FDA-cleared wearable pulse oximetry technology for infants, combined with a strong direct-to-consumer brand and a growing ecosystem of integrated hardware and software offerings that differentiate it through data-driven parenting insights.

The company serves individual consumers, primarily parents and caregivers of infants and young children, who purchase its products through direct-to-consumer online platforms and retail partners. Its customer base consists of households seeking technology-assisted solutions for infant monitoring and parental reassurance, with no specific institutional or commercial customer names disclosed in the filing.